Anticoagulation in type 2 myocardial infarctions: Lessons learned from the rivaroxaban in type 2 myocardial infarctions feasibility trial

por Gouda, Pishoy, Kay, Robert, Gupta, Arjun, Yuen, Tiffany, Elharram, Malik, Breau, Jean-Bernard, Gilani, Syed, Lau, Darren, Senaratne, Janek, Tsui, Albert KY., Tsuyuki, Ross, Graham, Michelle
Publicado 2023